4D Molecular Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Hi, everyone. Thanks for being here today. My name is Ranveer Gathwala. I'm a Vice President in the Healthcare Investment Banking Group at JPMorgan. We are very pleased to have 4D Molecular Therapeutics with us today. Today, we're joined by Dr. David Kirn, Founder and CEO of 4D Molecular Therapeutics. Dr. Kirn will run through a presentation, and I'll moderate with some questions for Q&A afterwards.
With that, I'll hand it over to Dr. Kirn to run through the presentation. Thank you.
All right. Thank you, and good morning. Thanks for having us present today, and thanks to all of you for being here bright and early. Again, I'm Dave Kirn, Co-Founder and CEO of 4D. And at 4D, we're developing a new backbone for retinal care and moving the field beyond the need for lifelong injections. So I'll be sharing with you some of our recent accomplishments as well as the future potential of the company.
So this is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
